• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

完全治疗与残余病变——急性冠状动脉综合征后的长期演变

Complete Treatment Versus Residual Lesion - Long-Term Evolution After Acute Coronary Syndrome.

作者信息

Soeiro Alexandre de Matos, Scanavini Filho Marco Antônio, Bossa Aline Siqueira, Zullino Cindel Nogueira, Soeiro Maria Carolina F Almeida, Leal Tatiana Carvalho Andreucci T, Serrano Carlos Vicente, Hajjar Ludhmila Abrahão, Kalil Filho Roberto, Oliveira Múcio Tavares

机构信息

Instituto do Coração (InCor), Hospital das Clínicas, Universidade de São Paulo, SP, Brazil.

出版信息

Arq Bras Cardiol. 2016 Dec;107(6):550-556. doi: 10.5935/abc.20160176.

DOI:10.5935/abc.20160176
PMID:28558085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5210459/
Abstract

INTRODUCTION

A recently published study raised doubts about the need for percutaneous treatment of nonculprit lesions in patients with acute coronary syndromes (ACS).

METHODS

Retrospective, unicentric, observational study.

OBJECTIVE

To analyze the long-term outcomes in patients undergoing treatment of the culprit artery, comparing those who remained with significant residual lesions in nonculprit arteries (group I) versus those without residual lesions in other coronary artery beds (group II). The study included 580 patients (284 in group I and 296 in group II) between May 2010 and May 2013. We obtained demographic and clinical data, as well as information regarding the coronary treatment administered to the patients. In the statistical analysis, the primary outcome included combined events (reinfarction/angina, death, heart failure, and need for reintervention). The comparison between groups was performed using the chi-square test and ANOVA. The long-term analysis was conducted with the Kaplan-Meier method, with a mean follow-up of 9.86 months.

RESULTS

The mean ages were 63 years in group I and 62 years in group II. On long-term follow-up, there was no significant difference in combined events in groups I and II (31.9% versus 35.6%, respectively, p = 0.76).

CONCLUSION

The strategy of treating the culprit artery alone seems safe. In this study, no long-term differences in combined endpoints were observed between patients who remained with significant lesions compared with those without other obstructions.

摘要

引言

最近发表的一项研究对急性冠状动脉综合征(ACS)患者非罪犯病变的经皮治疗必要性提出了质疑。

方法

回顾性、单中心观察性研究。

目的

分析罪犯血管接受治疗的患者的长期结局,比较非罪犯血管仍有明显残余病变的患者(I组)与其他冠状动脉床无残余病变的患者(II组)。该研究纳入了2010年5月至2013年5月期间的580例患者(I组284例,II组296例)。我们获取了人口统计学和临床数据,以及患者接受冠状动脉治疗的相关信息。在统计分析中,主要结局包括复合事件(再梗死/心绞痛、死亡、心力衰竭和再次干预需求)。组间比较采用卡方检验和方差分析。长期分析采用Kaplan-Meier方法,平均随访9.86个月。

结果

I组平均年龄为63岁,II组为62岁。在长期随访中,I组和II组的复合事件无显著差异(分别为31.9%和35.6%,p = 0.76)。

结论

仅治疗罪犯血管的策略似乎是安全的。在本研究中,与无其他阻塞的患者相比,有明显病变的患者在复合终点方面未观察到长期差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bace/5210459/c895d0ebf5cb/abc-107-06-0550-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bace/5210459/2342168e7988/abc-107-06-0550-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bace/5210459/4bdc136e3d2e/abc-107-06-0550-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bace/5210459/c895d0ebf5cb/abc-107-06-0550-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bace/5210459/2342168e7988/abc-107-06-0550-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bace/5210459/4bdc136e3d2e/abc-107-06-0550-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bace/5210459/c895d0ebf5cb/abc-107-06-0550-g03.jpg

相似文献

1
Complete Treatment Versus Residual Lesion - Long-Term Evolution After Acute Coronary Syndrome.完全治疗与残余病变——急性冠状动脉综合征后的长期演变
Arq Bras Cardiol. 2016 Dec;107(6):550-556. doi: 10.5935/abc.20160176.
2
Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study.非纤维粥样硬化病变表型与长期临床结局:来自 PROSPECT 研究的一项亚组研究分析。
JACC Cardiovasc Imaging. 2013 Aug;6(8):908-16. doi: 10.1016/j.jcmg.2013.04.008. Epub 2013 Jul 10.
3
Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.性别与急性冠状动脉综合征中的冠状动脉粥样硬化程度、斑块成分和临床结局的关系。
JACC Cardiovasc Imaging. 2012 Mar;5(3 Suppl):S62-72. doi: 10.1016/j.jcmg.2012.02.003.
4
Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes.代谢综合征或糖尿病的急性冠脉综合征患者的斑块成分与临床结局。
JACC Cardiovasc Imaging. 2012 Mar;5(3 Suppl):S42-52. doi: 10.1016/j.jcmg.2012.01.008.
5
Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.SYNTAX 评分残余值对 ACS 患者功能性完全血运重建后的预后价值。
J Am Coll Cardiol. 2018 Sep 18;72(12):1321-1329. doi: 10.1016/j.jacc.2018.06.069.
6
Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy).非罪犯血管心肌灌注对急性冠状动脉综合征经皮冠状动脉介入治疗患者结局的影响:来自 ACUITY 试验(急性血管造影和紧急介入治疗策略)的分析。
JACC Cardiovasc Interv. 2014 Mar;7(3):266-75. doi: 10.1016/j.jcin.2013.08.016.
7
Instantaneous wave-free ratio for guiding treatment of nonculprit lesions in patients with acute coronary syndrome: A retrospective study.瞬时无波比在急性冠状动脉综合征患者非罪犯病变治疗中的指导作用:一项回顾性研究。
Catheter Cardiovasc Interv. 2022 Feb;99(2):489-496. doi: 10.1002/ccd.30025. Epub 2021 Dec 4.
8
Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).血流储备分数指导下的完全血运重建改善 ST 段抬高型心肌梗死合并严重非罪犯病变患者的预后:DANAMI 3-PRIMULTI 子研究(ST 段抬高型心肌梗死合并多支血管病变患者的直接经皮冠状动脉介入治疗:仅治疗罪犯病变还是完全血运重建)
Circ Cardiovasc Interv. 2017 Apr;10(4). doi: 10.1161/CIRCINTERVENTIONS.116.004460.
9
Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes.伴有和不伴有慢性肾脏病的急性冠状动脉综合征患者的冠状动脉斑块成分、形态和结局。
JACC Cardiovasc Imaging. 2012 Mar;5(3 Suppl):S53-61. doi: 10.1016/j.jcmg.2011.12.008.
10
Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study.PROSPECT 研究中急性冠脉综合征患者非罪犯斑块破裂的临床转归。
JACC Cardiovasc Imaging. 2014 Apr;7(4):397-405. doi: 10.1016/j.jcmg.2013.10.010. Epub 2014 Mar 13.

本文引用的文献

1
[V Guideline of the Brazilian Society of Cardiology on Acute Myocardial Infarction Treatment with ST Segment Elevation].[巴西心脏病学会关于ST段抬高型急性心肌梗死治疗的V指南]
Arq Bras Cardiol. 2015 Aug;105(2 Suppl 1):1-105. doi: 10.5935/abc.20150107.
2
Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.急性ST段抬高型心肌梗死合并多支血管病变患者行直接经皮冠状动脉介入治疗时完全血运重建与仅对罪犯病变血运重建的随机试验:CvLPRIT试验
J Am Coll Cardiol. 2015 Mar 17;65(10):963-72. doi: 10.1016/j.jacc.2014.12.038.
3
Target-vessel versus multivessel revascularisation in ST-elevation myocardial infarction: a meta-analysis of randomised trials.
ST段抬高型心肌梗死中靶血管与多支血管血运重建:随机试验的荟萃分析
Heart Lung Circ. 2015 Apr;24(4):327-34. doi: 10.1016/j.hlc.2014.10.013. Epub 2014 Dec 5.
4
Multi-vessel versus culprit-vessel and staged percutaneous coronary intervention in STEMI patients with multivessel disease: a meta-analysis of randomized controlled trials.多支血管病变与罪犯血管病变及分期经皮冠状动脉介入治疗在多支血管病变的ST段抬高型心肌梗死患者中的应用:一项随机对照试验的荟萃分析
Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):408-13. doi: 10.1016/j.carrev.2014.10.007. Epub 2014 Oct 16.
5
Management of multivessel coronary disease in STEMI patients: a systematic review and meta-analysis.ST段抬高型心肌梗死患者多支冠状动脉疾病的管理:一项系统评价和荟萃分析。
Int J Cardiol. 2015 Jan 20;179:552-7. doi: 10.1016/j.ijcard.2014.10.035. Epub 2014 Oct 22.
6
Culprit vessel only vs immediate complete revascularization in patients with acute ST-segment elevation myocardial infarction: systematic review and meta-analysis.急性ST段抬高型心肌梗死患者仅针对罪犯血管治疗与立即完全血运重建的比较:系统评价和荟萃分析
Clin Cardiol. 2014 Dec;37(12):765-72. doi: 10.1002/clc.22333. Epub 2014 Sep 18.
7
Culprit vessel only versus multivessel percutaneous coronary intervention in patients presenting with ST-segment elevation myocardial infarction and multivessel disease.ST段抬高型心肌梗死合并多支血管病变患者仅针对罪犯血管与多支血管行经皮冠状动脉介入治疗的比较
PLoS One. 2014 Mar 20;9(3):e92316. doi: 10.1371/journal.pone.0092316. eCollection 2014.
8
Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.多支血管病变患者行直接经皮冠状动脉介入治疗伴 ST 段抬高型心肌梗死:罪犯血管血运重建与完全血运重建的系统评价与荟萃分析。
Am Heart J. 2014 Jan;167(1):1-14.e2. doi: 10.1016/j.ahj.2013.09.018. Epub 2013 Oct 16.
9
Randomized trial of preventive angioplasty in myocardial infarction.随机对照试验预防心肌梗死的血管成形术。
N Engl J Med. 2013 Sep 19;369(12):1115-23. doi: 10.1056/NEJMoa1305520. Epub 2013 Sep 1.
10
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2013 Jan 29;127(4):e362-425. doi: 10.1161/CIR.0b013e3182742cf6. Epub 2012 Dec 17.